Nasovac-S Influenza Vaccine, Live, Attenuated (Human) | WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)

Vaccine type

Influenza, seasonal (Trivalent)

Commercial Name

Nasovac-S Influenza Vaccine, Live, Attenuated (Human)

Manufacturer

Serum Institute of India Pvt. Ltd.

URL

Responsible NRA

Central Drugs Standard Control Organization

Country

India

URL

Prequalification Status

Current

Effective Date

30/09/2015

Pharmaceutical Form

Lyophilised active component to be reconstituted with excipient diluent before use

Presentation

Vial + Ampoule

Number of Doses

Route of Administration

Intranasal

Storage Temperature

2-8°C

Vaccine Vial Monitor

Type 2

Secondary Packaging

Carton of 50 vials (active)(50 doses) [Dimensions 18.5x9.5x5.0 cm]; See remarks below

Tertiary Packaging

Box of 24 cartons of 50 vials (1200 vials/1200 doses) [Dimensions 60x48x41 cm]

Multidose Vial Policy

Not Applicable.

Vaccine Preservative

none

Cold Chain Volume

17.575 cm3/dose (in secondary packaging)

VPSAR (Vaccine Public Summary Assessment Report)

Package Insert

Container Photo